Spyre Therapeutics, Inc. (SYRE)
106.65
+0.16
(+0.15%)
USD |
NASDAQ |
Aug 24, 16:00
107.01
+0.36
(+0.34%)
Pre-Market: 08:54
Spyre Therapeutics 1 Year Total Returns (Daily) : 513.6% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 513.6% |
| August 21, 2026 | 534.6% |
| August 20, 2026 | 559.3% |
| August 19, 2026 | 576.1% |
| August 18, 2026 | 536.5% |
| August 17, 2026 | 517.1% |
| August 14, 2026 | 514.7% |
| August 13, 2026 | 485.3% |
| August 12, 2026 | 555.1% |
| August 11, 2026 | 573.7% |
| August 10, 2026 | 594.8% |
| August 07, 2026 | 588.4% |
| August 06, 2026 | 548.0% |
| August 05, 2026 | 518.6% |
| August 04, 2026 | 549.4% |
| August 03, 2026 | 483.8% |
| July 31, 2026 | 479.4% |
| July 30, 2026 | 487.0% |
| July 29, 2026 | 483.6% |
| July 28, 2026 | 488.7% |
| July 27, 2026 | 462.3% |
| July 24, 2026 | 480.3% |
| July 23, 2026 | 461.4% |
| July 22, 2026 | 501.4% |
| July 21, 2026 | 528.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 497.5% |
| July 17, 2026 | 493.4% |
| July 16, 2026 | 481.0% |
| July 15, 2026 | 566.7% |
| July 14, 2026 | 503.0% |
| July 13, 2026 | 497.4% |
| July 10, 2026 | 512.4% |
| July 09, 2026 | 496.7% |
| July 08, 2026 | 511.1% |
| July 07, 2026 | 515.9% |
| July 06, 2026 | 463.1% |
| July 02, 2026 | 458.9% |
| July 01, 2026 | 473.9% |
| June 30, 2026 | 493.1% |
| June 29, 2026 | 492.4% |
| June 26, 2026 | 448.6% |
| June 25, 2026 | 464.1% |
| June 24, 2026 | 459.6% |
| June 23, 2026 | 561.1% |
| June 22, 2026 | 568.4% |
| June 18, 2026 | 485.8% |
| June 17, 2026 | 476.4% |
| June 16, 2026 | 385.5% |
| June 15, 2026 | 383.4% |
| June 12, 2026 | 356.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AbbVie, Inc. | 29.50% |
| vTv Therapeutics, Inc. | 111.8% |
| BridgeBio Pharma, Inc. | 65.18% |
| Praxis Precision Medicines, Inc. | 654.5% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |